The deoxyglucose method for calculation of regional cerebral glucose metabolism by PET using '8F_ 2-fluoro-2-deoxy-d-glucose (FDG) requires knowledge of the lumped constant, which corrects for differences in the blood-brain barrier (BBB) transport and phosphorylation of FDG and glucose. The BBB transport rates of FDG and glucose have not previously been determined in hu mans. In the present study these transport rates were measured with the intravenous double-indicator method in 24 healthy subjects during normoglycemia (5.2 ± 0.7 mM). Nine subjects were restudied during moderate hy poglycemia (3.4 ± 0.4 mM) and five subjects were studied once during hyperglycemia (15.0 ± 0.7 mM). The global ratio between the unidirectional clearances of FDG and glucose (Kj */Kj) was similar in normoglycemia (1.48 ± 0.22), moderate hypoglycemia (1.41 ± 0.23), and hyperThe deoxyglucose method for estimation of re gional glucose metabolism in animal experiments was introduced by Sokoloff in 1977 (Sokoloff et aI.,
glycemia (1.44 ± 0.20). This ratio is comparable to what has been obtained in rats. We argue that the global ratio is constant throughout the brain and may be applied for the regional determination of LC. We also determined the transport parameters of the two hexoses from brain back to blood and, assuming symmetrical transport across the BBB, we found evidence of a larger initial distribution volume of FDG in brain (0.329 ± 0.236) as compared with that of glucose (0.162 ± 0.098, P < 0.005). The difference can be explained by the very short experimental time, in which FDG may distribute both intra-and extracellularly, whereas glucose remains in a volume comparable to the interstitial fluid of the brain. Key Words: BBB transport Glucose transport-FDG transport-Lumped constant Cerebral metabolic rate of glucose.
1977). The method was extended for use in humans by positron emission tomography (PET) with 18F_2_ fluoro-2-deoxY-D-glucose (FDG) as tracer (Phelps et aI., 1979; Reivich et aI., 1979) . This method de termines the net clearance of FDG from blood to brain (K *) and the net clearance of glucose (K) is then calculated by dividing K* by a correction fac tor, the lumped constant. The lumped constant con sists of two correction terms: a correction for the differences in the steady-state distribution volumes of FDG and glucose, and a correction for the dif ferences in affinity to the hexokinase enzyme, which is the first step in glycolysis. The steady-state distribution volumes are determined by the differ ences in both blood-brain barrier (BBB) transport rates and phosphorylation of the two hexoses. De termination of the differences in FDG and glucose BBB transport thus provides further insight into the determination of the lumped constant. Glucose BBB transfer follows Michaelis-Menten kinetics for facilitated transport (Crone, 1965) and 2-deoxy-D-glucose (deoxyglucose) is transported across the BBB by the same carrier (Oldendorf, 1971) . The kinetic parameters for BBB transport have been ob tained from experimental models for glucose and deoxyglucose (Cunningham and Cremer, 1981; Gjedde, 1982; Crane et aI., 1983; Spence et aI., 1990) , and simultaneous measurements of BBB transport of glucose and FDG have also been per formed in rats (Crane et aI., 1983; Fuglsang et aI., 1986) . These results suggest that the unidirectional BBB transfer from blood to brain for FDG is higher than for deoxyglucose, and that both glucose ana logs are transported at a higher rate than glucose itself. However, the relative transport ratios vary from study to study, and a recent study found no difference between the FDG and glucose BBB transfer (Lear and Ackerman, 1992) . It is also un clear to what extent the experimental data can be used in humans because the lack of a suitable method has prevented direct comparisons of differ ent hexoses' transport across the BBB in humans. With the introduction of the intravenous double indicator method (Knudsen et aI., 1994) , it is now possible to perform such studies in humans. The main purpose of the present study was to evaluate the relationship between the unidirectional clear ance from blood to brain of FDG (K] *) and glucose (K]) in humans using the intravenous double indicator method. To establish whether the ratio K]*/K] depends on plasma glucose concentration, measurements were performed during normo-, hy per-, and hypoglycemia. We also measured the per meability-surface area (PS) ratios for the two hex oses across the BBB, because we wanted to test the general assumption of symmetrical BBB hexose transport, that is, the PS ratio for transport from blood into the brain (PS] */PS]) should equal the PS ratio from the brain back to the blood (PS2 */PS2).
METHODS
Twenty-nine healthy volunteers (13 women and 16 men) of normal weight were studied. Mean age was 23 ± 4 years (range 20-34 years). Twenty-four subjects were studied under identical normoglycemic conditions. Nine of these subjects were restudied after moderate hypogly cemia induced by starvation. Five subjects were studied once during acute hyperglycemia. All subjects also had dynamic PET scans performed, and this part of the stud ies will be or has been published separately (Hasselbalch et ai., 1994) . Informed consent was obtained after written information, and the study was conducted according to the Helsinki Declaration II. The study was approved by a Danish ethical committee.
A small polyethylene catheter was inserted into the ra dial artery and into two antecubital veins during local analgesia. Using the Seldinger technique, a catheter was placed in the internal jugular vein percutaneously low on J Cereb Blood Flow Metab, Vol. 16, No.4, 1996 the neck as previously described (Hasselbalch et aI., 1994) . Hypoglycemia was induced by 3.5 days of total starvation. Each subject was allowed to drink only water, coffee, or tea, and was given 750 mg of potassium and a vitamin tablet each day. In the subjects studied during hyperglycemia, a hyperglycemic, normoinsulinemic clamp was induced by a constant infusion of somatostatin (0.6 mg kg-I h-I) and insulin (0.15 mIU kg-I min-I) and a variable glucose infusion of 20%. A plasma glucose level of 15 mM was reached within 1-1.5 h and plasma glucose was clamped at this level. BBB permeability studies were performed � 15 min later. In all subjects, BBB permeability studies of 1 min duration were per formed twice with �20-min interval and results were av eraged. During the second BBB study, background activ ity was monitored and subtracted.
CBF measurement
In the 24 subjects studied twice, CBF was determined by an intravenous bolus injection of 500-600 MBq 133Xe followed by recording of the clearance curves by 10 sta tionary detectors (Cerebrograph lOA, NOVO, Hadsund, Denmark). CBF was determined by the Initial Slope In dex method (Obrist et ai., 1975; Risberg et ai., 1975) . In the five hyperglycemic subjects, CBF was measured by the Kety-Schmidt technique at desaturation after 30 min of saturation by a constant infusion of 500-600 MBq 133Xe as described by Madsen et ai. (1993) .
Assuming a constant rate of cerehral oxygen use during the study, arteriovenous differences for oxygen were measured before the CBF and BBB permeability studies. CBF at the time of the BBB experiment, CBFBBB, was 
BBB permeability measurements
The double-indicator method adapted for studies in hu mans (L assen et aI., 1971 ) requires injection of a test and a BBB-impermeable tracer substance into the carotid ar tery. After a single passage through the brain vasculature, the activity of both tracers is measured in the jugular vein, and the extraction fraction of the test substance, which passes the BBB, is calculated as the relative dif ference between the time-activity curves of the test and reference substance. Introducing a three-compartment model has allowed for determination of transfer constants in the brain with correction for tracer backflux and cap illary heterogeneity (Knudsen et ai., 1990) . We used a recently developed modification of the method (Knudsen et ai., 1994) in which the test and reference substances are injected into a peripheral vein instead of into the carotid artery.
To correct for differences in the brain input of test and reference substances, a five-parameter Dirac impUlse re sponse for passage through the cerebrovascular bed is computed from the input and output curves of the refer ence substance (Knudsen et ai., 1994) . This response is then combined with a capillary model of the brain, the single membrane (well-mixed) model (Knudsen et ai., 1990) and convolved with the arterial input curve of the test substance to yield a theoretical test output curve that is iteratively compared with the actual test output curve. When the CBF is known, the values of the model vari-abIes and the standard errors of the estimates giving the best fit to the test curve can be obtained by minimizing the sum of squares of the differences between the theo retical and the measured outflow test curve by means of the simplex method. The unidirectional clearance (K 1 ) was calculated from the average unidirectional extraction fraction E of the test substance, and the CBF according to the formula: Kl = E x CBF. Transport from brain back to blood was estimated by the parameter PS 2 iV e' which is directly estimated in the double-indicator experiment, where PS 2 is the permeability-surface area for transport from brain back to blood and V c is the initial distribution volume of the tracer in brain.
A 5-1O-ml bolus, containing two test compounds and several BBB-impermeable reference compounds, was in jected intravenously through the antecubital catheter, and immediately afterwards the catheter was flushed with � 10 ml of saline. Starting 2-3 s before injection, contin uous samples of 1 ml of blood were collected for 50 s from the radial artery and jugular vein by means of a sampling machine (Ole Dich Instrumentmakers, Hvidovre, Den mark) at a fixed interval of 1.3 s.
Isotopes
The bolus for the double-indicator measurements con tained the following reference substances: 7 MBq 2 4Na + , 40 MBq 99mTc-diethylenetriamine pentaacetic acid e9mTc-DTPA), 0.4 MBq 36Cl-, and two test substances: 7 MBq 3H-glucose, and FDG labeled either with I.S MBq 14C or IS0--190 MBq 18F. 18F-FDG was obtained from Forschungszentrum Julich, Germany, with a specific ac tivity of 20 GBq/mg FDG and a radiochemical purity of >96%. 2 4Na + was obtained from Ris�, Denmark, 99mTc_ DTPA, 14C_FDG, 36CI-from Amersham (Amersham Corp., Arlington Heights, IL, U.S.A.), and 3H-glucose from Dupont (Stevenage, U.K.).
Blood samples were centrifuged immediately at 4°C and 300-fLi plasma samples were pipetted and counted in a gamma counter (COBRA 5003, Packard Instrument, Downers Grove, IL, U.S.A.) with subsequent correc tions for background, spillover, and decay. After at least 3 weeks, 3 ml of scintillation fluid (Picofluor 40, Packard) were added and 13 emission was counted (Packard P A SOO-CA, Packard) with corrections for quenching and spillover by the method of external standardization.
STATISTICS
Mean group values were compared with Mann Whitney U test. Intraindividual differences be tween two conditions were examined with the Wilcoxon matched-pairs test. A p value of <0.05 was considered statistically significant.
RESULTS
Patient data and plasma glucose are given in Ta ble 1. BBB permeability parameters for FDG and glucose are shown in Table 2 . KI was 0.098 ± 0.021 ml g -1 min -I (mean ± SD) in normoglycemia. Dur ing hypoglycemia, KI increased to 0.135 ± 0.022 ml g-I min -I (p < 0.001) and decreased to 0.047 ± 0.008 during hyperglycemia. The same pattern was seen for FDG, where KI* was 0.141 ± 0.028 in normoglycemia, increased during hypoglycemia to 0.188 ± 0.033 ml g-I min -I (p < 0.01) and de creased during hyperglycemia to 0.067 ± 0.005 ml g-I min -I . An example of an input-corrected intra venous double-indicator time-activity curve is shown in Fig. 1 , to demonstrate the higher brain extraction of FDG as compared with glucose. In two normoglycemic subjects, BBB permeabil ity for FDG could not be evaluated. In the remain ing 22 subjects, the mean of the individually deter mined KI*/KI ratios was 1.48 ± 0.22. This ratio did not change significantly with plasma glucose con centration (1.41 ± 0.23 in hypoglycemia and 1.44 ± 0.20 during hyperglycemia).
In Table 3 , PS products across the BBB are shown. PSI values for glucose and FDG were sim ilar to the KI values (Table 2) as expected when extraction is low. The PS2/Ve parameter was non significantly lower for FDG, but the ratio between the transport in and out of the brain [(PS2iV e)/PSI] was significantly lower for FDG (4.57 ± 2.86 com pared with 8.52 ± 4.70 for glucose, p < 0.005). As suming symmetrical transport across the BBB (PSI = PS2), the initial distribution volume (V e) can be estimated, and Ve for FDG was found to be twice that for glucose (0.329 ± 0.236 and 0.162 ± 0.098, respectively, p > 0.005).
DISCUSSION
Absolute values of unidirectional clearances of FDG and glucose Direct measurements of simultaneous FDG and glucose transport across the BBB in humans have not been obtained previously. In the present study, the absolute value for the unidirectional glucose ex traction fraction (E) across the BBB was 16.3% in normoglycemia (Table 2) , which is similar to values obtained both with the intracarotid double-indicator method (Knudsen et al., 1990) and with l I e-glucose PET studies as tracer in humans (Blomqvist et al., 1990) . We determined the unidirectional clearances Values are mean ± SD] Hypoglycemia: nine subjects were restudied after 3.5 days of total starvation. Differences between baseline group values and hypoglycemic group values were tested by Mann-Whitney U test. a p < 0.001. b P < om. 
Values are mean ± SD. CBF, cerebral blood flow;E, unidirectional extraction of glucose; E, unidirectional extraction fraction of FDG; K1: unidirectional clearance of glucose, Kl*' unidirectional clearance of FDG. Unidirectional clearance was calculated from KI = CBF x E. Normoglycemia, mean plasma glucose 5.2 ± 0.7 mM; hypoglycemia, nine subjects were restudied after 3.5 days of total starvation (mean plasma glucose 3.4 ± 0.4 mM). Hyperglycemia, five subjects were studied once during a hyperglycemic clamp (mean plasma glucose 15.5 ± 0.7). Differences between baseline group and hypoglycemic groups were tested by Mann-Whitney U test.
a Not significant.
of glucose (KJ) and FDG (KJ*) from E x CBF and E* x CBF. Our global mean KJ of 0.098 was higher than the values between 0.061 and 0.083 reported by Blomqvist et ai. (Blomqvist et aI., 1990 (Blomqvist et aI., , 1991 and our global mean K J * is also higher than values obtained in different PET centers from dynamic PET -FDG studies (Evans et al., 1986) . These dif ferences are probably due to methodological differ ences, especially the CBF measurements in the present study, which overestimate true global blood flow (Olesen et aI., 1971 namic PET are obtained in the same subjects with comparable methods, values obtained with the dou ble-indicator method are higher (Knudsen et aI., 1995) . The discrepancy could be explained by dif ference in the time of the experiment; BBB trans port parameters are estimated within 50 s with the double-indicator method, whereas dynamic PET BBB parameters are estimated from the first several minutes of the time-activity curves. Numerous technical factors, such as scan schedule and blood sampling, may affect the PET parameters, but also model limitations, especially the assumption of tis sue homogeneity, may lead to underestimation of "true" BBB parameter estimation with dynamic PET (Schmidt et aI., 1992) .
Kl*/Kl
As already stated, absolute values for KJ * and KJ should be considered with caution, because values depend on the method employed. However, the rel ative ratio between KJ* and KJ, which is the scope of this study, is not affected by factors that affect the hexoses identically. For instance, the use of dif ferent CBF methods does not affect the KJ */KJ ra tio because CBF is cancelled out in the ratio. Sim ilarly, other methodological errors would afflict the two hexoses identically. The tracers are injected in the same bolus and their activity is counted in the same blood samples, which minimizes any errors in timing and sample volume between the two tracers, the ratio therefore being well determined with a co efficient of variation ranging from 14 to 16%.
The ratio between the unidirectional clearances of FDG and glucose (KJ*/KJ) was 1.48 in normo glycemia. With the use of the brain uptake index method (Oldendorf, 1971) , Crane et al. (1983) mea sured the BBB parameters for FDG and glucose in normoglycemic rats. The KJ */KJ ratio was 1.67, pri marily because FDG had a higher affinity for the Values are mean ± SD. PSI' permeability-surface area product of transport from blood to brain; PSzVe, permeability-surface area product of transport from brain to blood divided by Ve, where Ve is the initial distribution volume of tracer in the brain. PSziV e is equal to the fractional clearance of tracer (k2) and is directly determined from the double-indicator experiment, Ve is calculated by assuming PSI = PS2. a p < 0.00001. b P < 0.005, two-sample t test for difference between glucose and FDG.
glucose carrier than glucose itself [Kt (half saturation constant) for FDG was 6.9 versus 11.0 mM for glucose, whereas T max (maximal transport rate) was not significantly different (1. 70 versus 1.42 flmol g-I min -I )]. Fuglsang et al. (1986) re ported a similar K\ */KI ratio of 1.65 in normogly cemic rats using a rapid time-integral method. The value of 1.48 reported in the present study is com parable to the values obtained in rats, indicating no species difference with regard to this ratio.
The absolute values for KI* and K\ changed with changes in glucose concentration, reflecting that the transport of hexoses follows Michaelis-Menten ki netics for facilitated diffusion. Statistical evaluation of these changes were only partly possible due to differences in the methodological setup between groups, but as stressed already, the KI */K1 ratios determined at different glucose levels were compa rable, and because the relative changes in KI * and KI were of the same magnitude, the KI*/KI ratio remained constant in the hypo-, normo-, and hyper glycemic conditions (plasma glucose 3.5, 5.4, and 15.5 mM, respectively). Theoretically, a constant ratio is expected from the Michaelis-Menten pa rameters describing KI* and K}, from which it can be seen that plasma glucose concentration cancels out in the ratio (KI*/KI = {Tmax */(Kt*[l + (Cpl Kt)]}/[T max/(Kt + Cp))), where Cp is plasma glucose concentration). Experimental verification of this linear correlation between the BBB transport of the two hexoses is illustrated in Fig. 2 . It is concluded that the K) */KI ratio remains constant within mod erate plasma glucose changes. This is crucial for the PET-FDG model, because the tracer must behave in a fixed relation to the native glucose molecule also in case of physiological and pathophysiological changes.
The question to be addressed is whether the ratio of 1.48, as determined globally in this study, can be applied regionally. The ratio of deoxyglucose and glucose influx has been found to be similar in cortical and central gray matter in the rat brain, as measured by the brain uptake index method (Par dridge et aI., 1982) . With the use of high-resolution autoradiograms, Lear and Ackerman (1992) re cently found that, apart from some neuronal layers in the hippocampus, the KI*/KI ratio was constant throughout the normal rat brain. These experimen tal studies are in accordance with previous PET studies in humans, in which the ratio between the distribution volumes of methylglucose and FDG showed almost no regional variation (Gjedde et aI., 1985) . Thus it can be assumed that under normal physiological conditions, the K) */KI ratio remains constant regionally, and that the global ratio ob tained in the present study equals the ratio in any single tissue in the normal brain.
Initial distribution volumes for FDG and glucose
PS products for transport across the BBB were also measured in the present study, and values for transport from blood to brain interstitial fluid (PSI) as well as values from brain interstitial fluid back to blood (PS2/V e) are shown in Table 3 . The ratio be tween these transport parameters [(PS2/V e)/PSd is different for glucose and FDG because PS2/V e is higher for glucose than for FDG. The model yields a PS2/V e ratio, and provided that BBB glucose transport is symmetrical, the difference in the PS21 Ve ratios for FDG and glucose must be explained by differences in the initial distribution volumes of the two hexoses. With the very short experimental time of the double-indicator method, glucose distributes in a volume that equals the interstitial volume in the brain (Knudsen et aI., 1990) , but FDG seems to distribute in a larger volume including both extra and intracellular volumes, which may be caused by a faster FDG transport into neurons and glia cells. The present study has demonstrated that the BBB transporter has a 50% faster transport rate for FDG than for glucose, and if the same was true for the glia and neuronal glucose transporters, FDG would )' Values are ml g-1 min-1. Each point represents values ob tained in a single subject as the mean value of two double indicator experiments, open circles are subjects studied dur ing normoglycemia, filled circles are subjects studied during hypoglycemia, and triangles are subjects studied during hy perglycemia. The straight line is a linear regression line.
indeed distribute in a larger brain volume than glu cose does. Although the neuronal glucose trans porter differs from the BBB transporter (GLUT3 and GLUTl subtypes, respectively), in vitro stud ies of cell cultures have revealed that deoxyglucose has a higher affinity than glucose to the GLUT3 transporter (Asano et al., 1992) , with a half saturation constant (Kt) of 0. 8-0. 9 mM compared with 3.4-3.6 mM for 3-0-methylglucose. Thus, the same relationship may exist in vivo for GLUT3 in humans, and in Table 3 we have illustrated the pos sible difference in initial distribution volumes for the two tracers (Ve and Ve *). It can be seen that glucose distributes in a volume of 0.16, which is comparable to the brain interstitial volume (Fen stermacher and Patlak, 1975) , whereas FDG distrib utes in a much larger volume of 0.33. However, this volume is still smaller than the brain' s aqueous phase of -0.80, which is the final distribution vol ume of glucose and FDG. It is therefore possible that FDG, during an experimental time of 40-50 s, is taken up by a fraction of the cells of the brain, whereas the entry of glucose into these cells is slower. With the use of the well-mixed model trans fer of tracer from interstitial fluid into intracellular space is determined as a separate parameter, k3 (Knudsen et al., 1990) . In the present study, how ever, a great variation in this parameter did not al low any statistical evaluation of this parameter, and Vol. 16, No.4, 1996 the aforementioned hypothesis thus could not be experimentally confirmed. However, the difference in distribution volumes of the two hexoses, which, from a physiological point of view, is plausible, can explain all of the difference in the PS2/V e parame ters, and the data in the present study do not con tradict the assumption of symmetrical BBB trans port. Moreover, it is generally assumed that trans port of glucose (and FDG) is symmetrical (Pardridge and Oldendorf, 1975; Gjedde and Chris tensen, 1984) , and no studies have so far rejected this assumption.
Determination of the lumped constant
To what extent the information obtained in the present study on the BBB transport of FDG and glucose can be applied in the regional determination of the lumped constant remains to be determined. The original model proposed by Sokoloff et al. (1977) requires that the lumped constant is either measured or is estimated from knowledge of the differences in BBB transport rates and phosphory lation of deoxyglucose (or FDG) and glucose. By assuming a constant and symmetrical transport of tracer and glucose across the BBB, the steady-state distribution volumes are determined by the ratios K] */K] and k3 */k3 (the ratio of the phosphorylation rates of the two hexoses). Consequently, if these two ratios are known, the lumped constant can be calculated from kinetic parameters determined in a dynamic PET-FDG study [lumped constant = k 3 */ k3 + (K]*/K] -k3*/k3) x (k3*/(k2* + k3*) ' Kuwa bara et al., 1990; Holden et aI., 1991] . This ap proach is tempting, because it allows for a pixel-by pixel calculation of the lumped constant. However, even if the K] */K] obtained in the present study represent "true" BBB transport and potentially could be implemented in the determination of the lumped constant as argued herein, the k3*/k3 value has not been determined in humans. Moreover, most methodological problems that afflict the dy namic PET model will also affect the calculation of the lumped constant. Further studies are needed to evaluate to what extent regional calculation of the lumped constant with inclusion of the present ratio will yield reliable values for regional or global glu cose metabolism.
In conclusion, under normal physiological condi tions in humans, 1.48 is a reliable estimate for the ratio between FDG and glucose unidirectional brain clearances. The ratio is constant with changes in plasma glucose from 3.5 to 15 mM. Estimation of PS products across the BBB revealed a lower PSzI Ve ratio for FDG as compared with glucose, but the difference may be explained by differences in the initial distribution volume for the two tracers. It is argued that the global ratio can be applied region ally, and this stability of the ratio allows the poten tial for a direct determination of the lumped con stant from dynamic PET kinetic parameters. How ever, this kinetic approach for determination of the lumped constant should be further validated, and especially the phosphorylation coefficient should be determined in human brain tissue.
